News

Steam has added yet more free-to-play games to its already massive library. Here are some of the coolest-looking ones.
Bandai Namco Studios' 2D action platformer Shadow Labyrinth transforms gaming icon Pac-Man into a challenging side-scrolling ...
Gran Turismo is one of the greatest racing game franchises of all time, and it all began with a game from the '90s offered on ...
Are you looking for the best iPhone apps? We take a deep dive into what the App Store has to offer, finding you the best ...
Kevin Systrom accused Mark Zuckerberg of stifling Instagram's growth. Systrom claimed Facebook resources were diverted away from Instagram. He testified about receiving no additional staffing for ...
Ghost of Yotei, the sequel to Ghost of Tsushima, is set to release on October 2, 2025. Set in 1603 Japan near Mount Yotei, the game introduces a new protagonist, Atsu, and focuses on her quest for ...
From developer Supermassive Games, the choose-your-own-nightmare experience is often enjoyed as a multi-player affair. It lets you and your friends embody an entire cast of classic genre ...
Some people worry that the platform, which hosts millions of user-generated games and encourages kids to chat with each other, is an attractive target for predators. Others simply worry that there ...
“Our fundamental thesis right now is that game discovery and user acquisition is is broken. We’re building a platform with Reach to solve that problem in two different ways.” Chris DeWolfe ...
Bethesda has dropped its new Oblivion Remastered trailer after a month stuffed with leaks and teases, and we thankfully don't have long to wait until we can return to the adventure across Tamriel.
The showcase culminated with a first-ever global screening of “Lost in Starlight” for Tokyo attendees, signaling Netflix’s confidence in its expanding Korean genre portfolio.
The boxing world is still awaiting an official announcement for the rematch between Gervonta "Tank" Davis and Lamont Roach Jr. after these two fought to a majority draw on March 1. All indications ...